Cancer Vaccine by Fusions of Dendritic and Cancer Cells
Dendritic cells (DCs) are potent antigen-presenting cells and play a central role in the initiation and regulation of primary immune responses. Therefore, their use for the active immunotherapy against cancers has been studied with considerable interest. The fusion of DCs with whole tumor cells repr...
Main Authors: | Shigeo Koido, Eiichi Hara, Sadamu Homma, Yoshihisa Namiki, Toshifumi Ohkusa, Jianlin Gong, Hisao Tajiri |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2009-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2009/657369 |
Similar Items
-
Antigen-Specific Polyclonal Cytotoxic T Lymphocytes Induced by Fusions of Dendritic Cells and Tumor Cells
by: Shigeo Koido, et al.
Published: (2010-01-01) -
Regulation of Tumor Immunity by Tumor/Dendritic Cell Fusions
by: Shigeo Koido, et al.
Published: (2010-01-01) -
Immunologic Monitoring of Cellular Responses by Dendritic/Tumor Cell Fusion Vaccines
by: Shigeo Koido, et al.
Published: (2011-01-01) -
In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells
by: Sagawa Yukiko, et al.
Published: (2008-09-01) -
Dendritic-Tumor Fusion Cell-Based Cancer Vaccines
by: Shigeo Koido
Published: (2016-05-01)